Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis
Jaszczyński J, Wilk W, Kruczak A, et al. Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis. Polish Journal of Pathology. 2015;66(4):420-425. doi:10.5114/pjp.2015.57257.
APA
Jaszczyński, J., Wilk, W., Kruczak, A., Wohadlo, Ł., Faron, P., & Łuczyńska, E. et al. (2015). Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis. Polish Journal of Pathology, 66(4), 420-425. https://doi.org/10.5114/pjp.2015.57257
Chicago
Jaszczyński, Janusz, Wacław Wilk, Anna Kruczak, Łukasz Wohadlo, Piotr Faron, Elżbieta Łuczyńska, and Piotr Chłosta et al. 2015. "Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis". Polish Journal of Pathology 66 (4): 420-425. doi:10.5114/pjp.2015.57257.
Harvard
Jaszczyński, J., Wilk, W., Kruczak, A., Wohadlo, Ł., Faron, P., Łuczyńska, E., Chłosta, P., Stelmach, A., and Jakubowicz, J. (2015). Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis. Polish Journal of Pathology, 66(4), pp.420-425. https://doi.org/10.5114/pjp.2015.57257
MLA
Jaszczyński, Janusz et al. "Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis." Polish Journal of Pathology, vol. 66, no. 4, 2015, pp. 420-425. doi:10.5114/pjp.2015.57257.
Vancouver
Jaszczyński J, Wilk W, Kruczak A, Wohadlo Ł, Faron P, Łuczyńska E et al. Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis. Polish Journal of Pathology. 2015;66(4):420-425. doi:10.5114/pjp.2015.57257.
Between 1990 and 1999, 182 men were treated for non-seminomatous germ cell testicular tumours. In 24 of them after chemotherapy a residual retroperitoneal mass was removed. In 14 of them additional immunohistochemical (IHC) examinations using antibodies against cytokeratins, vimentin, PLAP, CD30, AFP, βhCG, p53, and MIB-1 were performed. We compared the results of those additional studies with the results of routine histopathological examination. Histological assessment revealed most frequently (ca. 54% of cases) non-neoplastic lesions, i.e. fibro-cystic, necrotic or inflammatory tumours and lymphatic tissue. In about 33% of cases, surviving live neoplastic cells were found.
